May 14, 2024

Workvivo by Zoom is named preferred migration partner for Workplace from Meta

Meta is discontinuing Workplace and will partner with Workvivo to assist with customer transitions. SAN JOSE, Calif., May 14, 2024 (GLOBE NEWSWIRE) — Today, Workvivo by Zoom was named Meta’s only preferred migration partner for its customers as it retires Workplace from Meta. Meta is discontinuing Workplace from Meta – its employee engagement platform. To assist […]

Mitsumi Distribution spearheading Technological Advancement at GITEX Africa 2024.

DUBAI, UAE – African Media Agency – 14 May 2024 – Mitsumi Distribution, a leading IT, Telco, Value and AI distributor in the Middle East and Africa, proudly announces its participation in GITEX Africa 2024. With a widespread presence spanning 28 countries and strategic partnerships with over 27+ vendors, Mitsumi Distribution is poised to showcase front-line […]

MedSource Labs Announces Innovation in Safety, Accuracy and Functionality of IV Catheters

MedSource Labs Unveils ClearSafe Comfort® and TrueSafe Comfort® Blood Control Safety IV Catheters to protect medical staff and patients [Minneapolis, Minnesota, Chanhassen], May 14, 2024 (GLOBE NEWSWIRE) — MedSource Labs moves the needle in the peripheral safety IV market with the announcement of ClearSafe Comfort and TrueSafe Comfort Blood Control IV Catheters with groundbreaking active […]

‫ميتسومي للتوزيع تقود التقدم التكنولوجي في معرض جيتكس أفريقيا 2024

دبي، الإمارات العربية المتحدة – 14 مايو 2024 – تعلن شركة ميتسومي للتوزيع، الشركة الرائدة في مجال توزيع تكنولوجيا المعلومات والاتصالات وعروض القيمة والذكاء الاصطناعي في الشرق الأوسط وإفريقيا، بفخر عن مشاركتها في معرض جيتكس أفريقيا 2024. ومع تواجد واسع النطاق يشمل 28 دولة فضلاً عن الشراكات الاستراتيجية مع أكثر من 27 بائعًا، تستعد شركة […]

Nyxoah to Release First Quarter 2024 Financial Results on May 14, 2024

Mont-Saint-Guibert, Belgium – May 13, 2024, 10:30pm CET / 4:30pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA), today announced that the Company will release financial results for the first quarter 2024 on […]